Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer

Laryngoscope

Volumn 108, Issue 3, 1998, Pages 345-350

  Nogueira, Christine P ^b   Dolan, Robert W ^b   Gooey, John ^b   Byahatti, Seema ^b   Vaughan, Charles W ^b   Fuleihan, Nabil S ^b   Grillone, Gregory ^b   Baker, Errol ^a   Domanowski, Gerard ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENE REPRESSION; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENES, BCL-1; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; TREATMENT OUTCOME;

EID: 0031905183     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199803000-00007     Document Type: Article

References (15)

1. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 1992;52: 5997-6000.
2. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995;332(11):712-6.
3. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53:4477-80.
4. Li X, Lee NK, Ye Y-W, et al. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 1994;86(20):1524-9.
5. Nawroz H, Riet P v-d, Hruban RH, et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994; 54:1152-5.
6. Field JK, Pavelic ZP, Spandidos DA, et al. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1993;119:1118-22.
7. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl1 linked candidate. Nature 1991;350:512-5.
8. Williams ME, Gaffey MJ, Weiss LM, et al. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:1238-43.
9. Callender T, El-Naggar AK, Lee MS, et al. Prad-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila) 1994;74:152-8.
10. Incognito LS, Blevins JD, Cordero J, et al. DNA amplification at chromosome 11q13 is associated with lymph node metastasis in head and neck cancer. Head Neck 1994;16(5): 500-8.
11. Jares PL, Fernandez PL, Campo E, et al. Prad-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-7.
12. Michalides R, Van Veelen N, Hart A, et al. Overexpression of Cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
13. Hahn M, Serth J, Fislage R, et al. Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene. Clin Chem 1993; 39(3):549-50.
14. De la Calle-Martin O, Fabregat V, Romero M, et al. AccII polymorphism of the p53 gene. Nucl Acid Res 1990; 18:4963.
15. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.